interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development
EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).
The EU Clinical Trials Register currently displays
44300
clinical trials with a EudraCT protocol, of which
7354
are clinical trials conducted with subjects less than 18 years old.
The register also displays information on
18700
older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see
Frequently Asked Questions ).
8 result(s) found for: Adenoviridae.
Displaying page 1 of 1.
EudraCT Number: 2022-002955-20
Sponsor Protocol Number: ADENO-beta
Start Date*: 2023-11-22
Sponsor Name:AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO
Full Title: Double-blind randomized controlled study versus placebo to evaluate the efficacy of mono-administration of betamethasone in children with symptomatic Adenovirus infection (ADENO-beta).
Medical condition: Pediatric patients diagnosed with symptomatic Adenovirus infection.
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
Population Age: Infants and toddlers, Children, Under 18
Full Title: A Phase I/II study to investigate the safety of Adenovirus specific T cells given to high-risk paediatric patients post allogeneic haematopoietic stem cell transplant (allo-HSCT) to treat reactivat...
Medical condition: Paediatric allogeneic stem cell transplant recipients at high risk of Adenovirus infection
Disease:
Version
SOC Term
Classification Code
Term
Level
17.0
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
17.0
10021881 - Infections and infestations
10021881
Infections and infestations
SOC
Population Age: Infants and toddlers, Children, Adolescents, Under 18
Full Title: A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients with Adenovirus Viremia
Medical condition: Treatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipients
Full Title: Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standar...
Medical condition: AdV infection in pediatric and adult allo HCT recipients receiving standard of care
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly
Full Title: Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)
Medical condition: Adenovirus (AdV), BK virus (BKV), John Cunningham virus (JCV), human herpesvirus 6 (HHV- 6), Epstein-Barr virus (EBV), and cytomegalovirus
(CMV) infections and/or disease in patients at high risk f...
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
20.1
10021881 - Infections and infestations
10055181
BK virus infection
PT
22.0
10021881 - Infections and infestations
10020431
Human herpesvirus 6 infection
PT
21.1
10021881 - Infections and infestations
10015108
Epstein-Barr virus infection
PT
20.1
10021881 - Infections and infestations
10011831
Cytomegalovirus infection
PT
21.1
10021881 - Infections and infestations
10023163
JC virus infection
PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly
Full Title: Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV...
Medical condition: Adenovirus (AdV), BK virus (BKV), John Cunningham virus (JCV), human herpesvirus 6 (HHV- 6), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) infections and/or disease in patients at high risk f...
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
20.1
10021881 - Infections and infestations
10055181
BK virus infection
PT
22.0
10021881 - Infections and infestations
10020431
Human herpesvirus 6 infection
PT
21.1
10021881 - Infections and infestations
10015108
Epstein-Barr virus infection
PT
20.1
10021881 - Infections and infestations
10011831
Cytomegalovirus infection
PT
21.1
10021881 - Infections and infestations
10023163
JC virus infection
PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly
Full Title: An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of A...
Medical condition: Treatment of adenovirus infections in high-risk pediatric allogeneic hematopoietic cell transplant recipients
Disease:
Version
SOC Term
Classification Code
Term
Level
20.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18
Full Title: Treatment of chemo-refractory viral infections after allogeneic
stem cell transplantation with multispecific T cells against CMV, EBV and AdV:
A phase III, prospective, multicentre clinical trial
Medical condition: Chemo-refactory AdV, CMV and EBV infections after allogeneic stem cell transplantation
Disease:
Version
SOC Term
Classification Code
Term
Level
22.0
10042613 - Surgical and medical procedures
10067859
Allogenic stem cell transplantation
PT
20.1
10021881 - Infections and infestations
10011831
Cytomegalovirus infection
PT
21.1
10021881 - Infections and infestations
10060931
Adenovirus infection
PT
21.1
10021881 - Infections and infestations
10015108
Epstein-Barr virus infection
PT
Population Age: Infants and toddlers, Children, Under 18, Adults, Elderly
Gender: Male, Female
Trial protocol:DE(Trial now transitioned)FR(Trial now transitioned)BE(Trial now transitioned)IT(Trial now transitioned)ES(Ongoing)
Trial results:(No results available)
Subscribe to this Search
To subscribe to the RSS feed for this search click
here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options:
Number of Trials to download:
Download Content:
Download Format:
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT